ZLAB

Zai Lab (ZLAB)

Zai Lab Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ZLAB

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/22	20 : 30	Business Wire	Zai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque Psoriasis	NASDAQ:ZLAB	Zai Lab Ltd
2024/05/20	13 : 21	Business Wire	Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China	NASDAQ:ZLAB	Zai Lab Ltd
2024/05/17	05 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZLAB	Zai Lab Ltd
2024/05/16	20 : 30	Business Wire	Zai Lab Announces Participation in May and June Investor Conferences	NASDAQ:ZLAB	Zai Lab Ltd
2024/05/16	05 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZLAB	Zai Lab Ltd
2024/05/15	02 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ZLAB	Zai Lab Ltd
2024/05/14	20 : 30	Business Wire	Zai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China	NASDAQ:ZLAB	Zai Lab Ltd
2024/05/13	09 : 20	Business Wire	Zai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China’s NMPA	NASDAQ:ZLAB	Zai Lab Ltd
2024/05/09	05 : 14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ZLAB	Zai Lab Ltd
2024/05/09	05 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZLAB	Zai Lab Ltd
2024/05/09	05 : 05	Business Wire	Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates	NASDAQ:ZLAB	Zai Lab Ltd
2024/04/15	20 : 30	Business Wire	Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024	NASDAQ:ZLAB	Zai Lab Ltd
2024/04/11	20 : 30	Business Wire	Zai Lab Statement on Executive Management Team’s Agreement on Share Activities	NASDAQ:ZLAB	Zai Lab Ltd
2024/04/02	20 : 30	Business Wire	Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs	NASDAQ:ZLAB	Zai Lab Ltd
2024/04/01	20 : 30	Business Wire	Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...	NASDAQ:ZLAB	Zai Lab Ltd
2024/03/27	22 : 29	Business Wire	Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer	NASDAQ:ZLAB	Zai Lab Ltd
2024/03/14	08 : 05	Business Wire	Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors	NASDAQ:ZLAB	Zai Lab Ltd
2024/03/07	06 : 01	Business Wire	Zai Lab to Present Final Overall Survival (OS) Data from Phase 3 NORA Study of ZEJULA (niraparib) in Platinum-Sensitive Recurrent Ovarian Cancer (PSROC)	NASDAQ:ZLAB	Zai Lab Ltd
2024/03/06	21 : 30	Business Wire	Zai Lab Announces Participation in March Investor Conference	NASDAQ:ZLAB	Zai Lab Ltd
2024/03/05	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZLAB	Zai Lab Ltd
2024/02/28	06 : 20	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ZLAB	Zai Lab Ltd
2024/02/28	06 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZLAB	Zai Lab Ltd
2024/02/28	06 : 05	Business Wire	Zai Lab Announces Full-Year 2023 Financial Results and Recent Corporate Updates	NASDAQ:ZLAB	Zai Lab Ltd
2024/02/09	06 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ZLAB	Zai Lab Ltd
2024/01/26	06 : 15	Business Wire	Zai Lab to Announce Full-Year 2023 Financial Results and Recent Corporate Updates on February 27, 2024	NASDAQ:ZLAB	Zai Lab Ltd
2024/01/11	07 : 12	Business Wire	Zai Lab Announces The New England Journal of Medicine Publication Demonstrating Durable Clinical Activity of Repotrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLC	NASDAQ:ZLAB	Zai Lab Ltd
2024/01/04	09 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZLAB	Zai Lab Ltd
2024/01/04	09 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZLAB	Zai Lab Ltd
2024/01/04	09 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ZLAB	Zai Lab Ltd
2024/01/04	05 : 50	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ZLAB	Zai Lab Ltd